Shandong Sito Bio-technology Co., Ltd. (SHE:300583)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Manufacturing	973.52M	918.22M	1.23B	1.24B	1.17B
Pharmaceutical Manufacturing Growth	6.02%	-25.06%	-1.35%	6.43%	32.71%
Unallocated Other	43.35M	52.38M	54.57M	70.11M	35.66M
Unallocated Other Growth	-17.24%	-4.01%	-22.16%	96.62%	56.68%
Total	1.02B	970.60M	1.28B	1.31B	1.20B
Total Growth	4.77%	-24.16%	-2.46%	9.10%	31.70%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	946.84M	790.60M	1.08B	1.18B	1.04B
China Growth	19.76%	-26.97%	-8.60%	13.62%	32.58%
Overseas	70.03M	180.01M	197.24M	127.67M	160.17M
Overseas Growth	-61.10%	-8.74%	54.49%	-20.29%	26.19%
Total	1.02B	970.60M	1.28B	1.31B	1.20B
Total Growth	4.77%	-24.16%	-2.46%	9.10%	31.70%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 15, 2026

Data Sources Report a data error